Bloom Energy heads into the final days of August in a genuinely split position: the stock has recovered sharply, short sellers are retreating, yet the same insiders who sold near the highs are still cashing out.
The most significant development since last week's note is the reversal in short interest. After building steadily to 8.7% of the free float — the level flagged in the August 19 piece — shorts have covered hard. Short interest dropped 10% on August 25 alone, pulling the position down to 7.7% of float. The weekly decline is 11%. That's a meaningful unwind in a short book that had been expanding for most of August. The stock's 6.6% single-day gain on August 25, on top of a 4% weekly advance and a 17.6% monthly move, almost certainly forced some of that covering. Borrow costs remain low — cost to borrow is at 0.47%, though that's up 39% on the week, reflecting a modest tightening as the stock ran. With availability at nearly 7,000% relative to short interest, the lending market is about as loose as it gets; there is no squeeze pressure here, and shorts who want to rebuild positions face essentially no friction in sourcing stock.
Options positioning reinforces the impression that this isn't a high-conviction directional week in either direction. The put/call ratio is at 1.06 — essentially in line with its 20-day average of 1.08 and a touch below neutral on a z-score basis. That's a notable de-escalation from the heavier defensive readings in late July, when the PCR was running above 1.2 for most of the month. The options market is no longer hedging aggressively against downside; it is also not chasing upside. The ORTEX short score has eased from around 40 to 37.8 over the past two weeks, consistent with the short cover and rising price but not yet signalling a crowded long setup.
The insider picture has not changed in character since last week's note — but it is worth stating plainly given the stock's bounce. The same cluster of directors and C-suite officers who sold between $205 and $251 in early-to-mid August has continued to distribute into the rally. Director Jeff Immelt sold 30,000 shares at $238.91 on August 17. Director John Chambers made two separate 15,000-share sales — one at $205, one at $250. The CCO, COO, and CLO all trimmed on August 14. Net selling value over the prior 90 days is approximately $38.5 million. With the stock now back at $217, the insiders who sold in the $230–$250 range are looking well-timed. Jane Street added over 10.7 million shares as reported at end-July, providing the clearest institutional buying signal in the holder list — but that move predates the current price level.
The Street has absorbed the post-earnings reset with a mixed set of moves. Most analysts lowered targets on or around July 29-30 — JPMorgan's Mark Strouse trimmed from $346 to $314 while keeping Overweight, UBS cut from $350 to $300 staying at Buy, Mizuho upgraded to Outperform but still pulled the target from $285 to $242. The consensus mean sits at $275, roughly 26% above the current price. On the other side, Jefferies raised its target from $188 to $229 on August 14 while staying at Hold — the most recent action, and somewhat at odds with the bullish consensus. Valuation is not for the faint-hearted: the EV/EBITDA multiple is 47x and the PE is 56x, though both have compressed roughly 7x and 6 points respectively over the past month as earnings expectations have improved faster than the price. EPS momentum ranks in the 95th-96th percentile on both 30- and 90-day horizons, which is the cleanest bull case the data provides.
The next earnings date is October 29. Between now and then, the two things worth tracking are whether the insider selling cluster continues as the stock pushes back toward the $230–$250 range where distributions were concentrated, and whether short interest re-builds following this week's cover — or whether the covering marks a genuine change in positioning rather than a tactical retreat by a short book caught in a momentum squeeze.
See the live data behind this article on ORTEX.
Open BE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
